Revance Therapeutics (RVNC) Form 3 Revance Therapeutics / Dustin S Sjuts ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Sjuts Dustin S

(Last) (First) (Middle)

C/O REVANCE THERAPEUTICS, INC

7555 GATEWAY BLVD

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/01/2019

3. Issuer Name and Ticker or Trading Symbol
Revance Therapeutics, Inc. [ RVNC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4,568(1)(2)	D
Common Stock	5,000(3)	D
Common Stock	2,500(4)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(5)	02/29/2028	Common Stock	28,000	29.85	D
Employee Stock Option (Right to Buy)	(6)	11/04/2028	Common Stock	30,000	24.96	D
Employee Stock Option (Right to Buy)	(7)	01/23/2029	Common Stock	10,000	17.23	D

Explanation of Responses:

1. The shares subject to the Restricted Stock award ("RSA") shall vest in four (4) equal annual installments beginning from April 15, 2018, subject to Mr. Sjuts' Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.

2. Excludes 432 shares withheld by and surrendered to the Issuer on April 15, 2019 to satisfy tax withholding obligations that arose in connection with vesting of the RSA for 5,000 shares.

3. The shares subject to the RSA shall vest in three (3) equal annual installments beginning from December 15, 2018, subject to Reporting Person's Continuous Service (as defined in the Plan) on each vesting date.

4. The shares subject to the RSA shall vest in three (3) equal annual installments beginning from February 15, 2019, subject to Reporting Person's Continuous Service on each vesting date.

5. The Option shall vest as follows: 25% of the shares subject to the Option shall vest on the first anniversary of the vesting commencement date of March 1, 2018, and 1/48th vesting each month thereafter subject to Reporting Person's Continuous Service as of each such vesting date.

6. The Option shall vest as follows: 1/48th of the total number of shares subject to the Option shall vest in 48 equal monthly installments over 4 years beginning from November 5,2018, subject to Reporting Person's Continuous Service as of each such vesting date.

7. The Option shall vest as follows: 1/48th of the total number of shares subject to the Option shall vest in 48 equal monthly installments over 4 years beginning from January 24, 2019, subject to Reporting Person's Continuous Service as of each such vesting date.

Remarks:

	/s/ Caryn McDowell, Attorney-in-Fact	12/10/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.